Reliability of sentinel lymph node biopsy for staging melanoma

British Journal of Surgery

Volumn 87, Issue 4, 2000, Pages 484-489

  Jansen, L ^a   Nieweg, O E ^a   Peterse, J L ^a   Hoefnagel, C A ^a   Valdes Olmos R A ^a   Kroon, B B R ^a  

^a ANTONI VAN LEEUWENHOEK HOSPITAL   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BLEU PATENTE V; DISULFINE BLUE; NANOCOLL TC 99M;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CLINICAL TRIAL; COHORT ANALYSIS; FEMALE; HUMAN; LYMPH NODE BIOPSY; LYMPH NODE METASTASIS; LYMPHOSCINTIGRAPHY; MAJOR CLINICAL STUDY; MALE; MELANOMA; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY;

ADOLESCENT; ADULT; AGED; FEMALE; FOLLOW-UP STUDIES; HUMANS; LOGISTIC MODELS; LYMPH NODES; MALE; MELANOMA; MIDDLE AGED; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; SKIN NEOPLASMS;

EID: 0034108863     PISSN: 00071323     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2168.2000.01362.x     Document Type: Article

References (20)

1. 1 Morton DL, Wen DR, Wong JH, Economou JS, Cagle LA, Storm FK et al. Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg 1992; 127: 392-9.
2. 2 Gershenwald JE, Tseng CH, Thompson W, Mansfield PF, Lee JE, Bouvet M et al. Improved sentinel lymph node localization in patients with primary melanoma with the use of radiolabeled colloid. Surgery 1998; 124: 203-10.
3. 3 Joseph E, Messina JL, Glass LF, Cruse CW, Rapaport DP, Berman CG et al. Radioguided surgery for the ultrastaging of the patient with melanoma. Cancer J Sci Am 1997; 3: 341-5.
4. 4 Pijpers R, Borgstein PJ, Meijer S, Hoekstra OS, van Hattum LH, Teule GJ. Sentinel node biopsy in melanoma patients: dynamic lymphoscintigraphy followed by intraoperative gamma probe and vital dye guidance. World J Surg 1997; 21: 788-92.
5. 5 Alex JC, Weaver DL, Fairbank JT, Rankin BS, Krag DN. Gamma-probe-guided lymph node localization in malignant melanoma. Surg Oncol 1993; 2: 303-8.
6. 6 Albertini JJ, Cruse CW, Rapaport D, Wells K, Ross M, DeConti R et al. Intraoperative radio-lympho-scintigraphy improves sentinel lymph node identification for patients with melanoma. Ann Surg 1996; 223: 217-24.
7. 7 Krag DN, Meijer SJ, Weaver DL, Loggie BW, Harlow SP, Tanabe KK et al. Minimal-access surgery for staging of malignant melanoma. Arch Surg 1995; 130: 654-8.
8. 8 Kapteijn BAE, Nieweg OE, Liem I, Mooi WJ, Balm AJM, Muller SH et al. Localizing the sentinel node in cutaneous melanoma: gamma probe detection versus blue dye. Ann Surg Oncol 1997; 4: 156-60.
9. 9 Nieweg OE, Jansen L, Kroon BBR. Technique of lymphatic mapping and sentinel node biopsy for melanoma. Eur J Surg Oncol 1998; 24: 520-4.
10. 10 Haddad FF, Stall A, Messina J, Brobeil A, Ramnath E, Glass LF et al. The progression of melanoma nodal metastasis is dependent on tumor thickness of the primary lesion. Ann Surg Oncol 1999; 6: 144-9.
11. 11 Bostick P, Essner R, Glass E, Kelley MC, Sarantou T, Foshag LJ et al. Comparison of blue dye and probe-assisted intraoperative lymphatic mapping in melanoma to identify sentinel nodes in 100 lymphatic basins. Arch Surg 1999; 134: 43-9.
12. 12 Leong SP, Steinmetz I, Habib FA, McMillan A, Gans JZ, Allen RE Jr et al. Optimal selective sentinel lymph node dissection in primary malignant melanoma. Arch Surg 1997; 132: 666-72.
13. 13 Lenisa L, Santinami M, Belli F, Clemente C, Mascheroni L, Patuzzo R et al. Sentinel node biopsy and selective lymph node dissection in cutaneous melanoma patients. J Exp Clin Cancer Res 1999; 18: 69-74.
14. 14 Borgstein PJ, Meijer S, van Diest PJ. Are locoregional cutaneous metastases in melanoma predictable? Ann Surg Oncol 1999; 6: 315-21.
15. 15 Gershenwald JE, Colome MI, Lee JE, Mansfield PF, Tseng C, Lee JJ et al. Patterns of recurrence following a negative sentinel lymph node biopsy in 243 patients with stage I or II melanoma. J Clin Oncol 1998; 16: 2253-60.
16. 16 Gershenwald JE, Thompson W, Mansfield PF, Lee JE, Colome MI, Tseng CH et al. Multi-institutional melanoma lymphatic mapping experience: the prognostic value of sentinel lymph node status in 612 stage I or II melanoma patients. J Clin Oncol 1999; 17: 976-83.
17. 17 Thompson JF, McCarthy WH, Bosch CMJ, O'Brien CJ, Quinn MJ, Paramaesvaran S et al. Sentinel lymph node status as an indicator of the presence of metastatic melanoma in regional lymph nodes. Melanoma Res 1995; 5: 255-60.
18. 18 Kapteijn BAE, Nieweg OE, Valdés Olmos RA, Liem IH, Panday RK, Hoefnagel CA et al. Reproducibility of lymphoscintigraphy for lymphatic mapping in cutaneous melanoma. J Nucl Med 1996; 37: 972-5.
19. 19 Mudun A, Murray DR, Herda SC, Eshima D, Shattuck LA, Vansant JP et al. Early stage melanoma: lymphoscintigraphy, reproducibility of sentinel node detection, and effectiveness of the intraoperative gamma probe. Radiology 1996; 199: 171-5.
20. 20 Nieweg OE, Kapteijn BAE, Thompson JF, Kroon BBR. Lymphatic mapping and selective lymphadenectomy for melanoma: not yet standard therapy. Eur J Surg Oncol 1997; 23: 397-8 (Editorial).